What is the debt of BioCardia this year?
BioCardia has a debt level of -1.1 USD this year.
BioCardia Debt 2024
BioCardia Debt
-1.1 USD
BioCardia Dividend yield
Ticker
BCDA
ISIN
US09060U5074
WKN
A2PLXH
In 2024, BioCardia's total debt was -1.1 USD, a -85.01% change from the -7.36 USD total debt recorded in the previous year.
BioCardia Aktienanalyse
What does BioCardia do?
BioCardia Inc is a medical technology company based in San Carlos, California, founded in 1994. They specialize in the development of medical devices used in the treatment of heart diseases. BioCardia has three main product lines: the Helix™ Biotherapy Platform, the Morph™ Transseptal Systems, and the CYPHER Select™ Balloon Catheter. The Helix™ Biotherapy Platform was developed to treat cardiovascular diseases using regenerative medicine. The system utilizes patient's own stem cells to repair damaged heart tissue and reduce the risk of heart attacks. This therapy method can significantly improve the quality of life and survival chances of patients with heart diseases. The Morph™ Transseptal Systems are used for minimally invasive removal of blood clots. They consist of a flexible guide wire and a catheter device that allows the doctor to remove the clot in the heart without performing an open surgery. This procedure is faster, safer, and less invasive than conventional methods. The CYPHER Select™ Balloon Catheter is used to open narrowed arteries in the heart. The balloon is inserted into the artery and inflated to break up the narrowing. Then, a medication is released to prevent the recurrence of the narrowing. This procedure is minimally invasive and enables faster recovery of patients. BioCardia is also involved in clinical research and collaborates closely with renowned institutions such as the Stanford University Medical Center. Through clinical studies, BioCardia collects important data on the efficacy and safety of its products. The results of these studies are published in medical journals and contribute to the advancement of medical practice. BioCardia's business model is based on the development and commercialization of innovative medical devices for the treatment of heart diseases. The company has built a portfolio of products and platforms that allow it to specialize in various areas of cardiovascular medicine. BioCardia also utilizes partnerships and collaborations to market its products and services. Overall, BioCardia is one of the leading companies in the field of medical devices for the treatment of heart diseases. With a portfolio of innovative products and a strong presence in medical research, BioCardia is well positioned to solidify its position as a market leader in the industry. BioCardia ist eines der beliebtesten Unternehmen auf Eulerpool.com.Debt Details
Understanding BioCardia's Debt Structure
BioCardia's total debt refers to the cumulative financial obligations the company owes to external parties. This can include short-term and long-term borrowings, bonds, loans, and other financial instruments. Assessing the company's debt levels is crucial for evaluating its financial health, risk profile, and ability to fund operations and expansions.
Year-to-Year Comparison
Analyzing BioCardia's debt structure over the years provides insights into the firm’s financial strategy and stability. A reduction in debt can indicate financial strength and operational efficiency, while an increase may signal growth investments or potential financial challenges ahead.
Impact on Investments
Investors pay close attention to BioCardia’s debt levels as they can influence the company’s risk and return profiles. Excessive debt can lead to financial strain, while moderate and well-managed debt can be a catalyst for growth and expansion, making it a critical aspect of investment evaluations.
Interpreting Debt Fluctuations
Shifts in BioCardia’s debt levels can be attributed to various operational and strategic factors. An increase in debt might be geared towards funding expansion projects or enhancing operational capacity, while a decrease may indicate profit realizations or an approach to minimize financial risk and leverage.
Frequently Asked Questions about BioCardia Stock
What was the debt of BioCardia compared to the previous year?
The debt of BioCardia has increased by -85.01% compared to the previous year dropped.
What are the consequences of high debt for investors in BioCardia?
High debt can pose a risk for investors of BioCardia, as it can weaken the company's financial position and hinder its ability to fulfill its obligations.
What are the consequences of low debt for investors of BioCardia?
Low debt means that BioCardia has a strong financial position and is able to fulfill its obligations without overburdening its finances.
How does an increase in debt from BioCardia affect the company?
An increase in debt of BioCardia can adversely affect the financial condition of the company and result in a higher burden on its finances.
How does a reduction of debt of BioCardia affect the company?
A reduction in debt of BioCardia can strengthen the company's financial position and improve its ability to meet its financial obligations.
What are some factors that influence the debt of BioCardia?
Some factors that can influence the debt of BioCardia include investments, acquisitions, operating costs, and revenue development.
Why are the debts of BioCardia so important for investors?
The debts of BioCardia are important for investors as they serve as an indicator of the company's financial stability. It provides investors with information on how the company fulfills its financial obligations.
What strategic measures can BioCardia take to change the debt?
To change the debt, BioCardia can take measures such as cost savings, increasing revenue, selling assets, making investments, or forming partnerships. It is important for the company to conduct a thorough review of its financial situation to determine the best strategic actions to change its debt.
How much dividend does BioCardia pay?
Over the past 12 months, BioCardia paid a dividend of . This corresponds to a dividend yield of about . For the coming 12 months, BioCardia is expected to pay a dividend of 0 USD.
What is the dividend yield of BioCardia?
The current dividend yield of BioCardia is .
When does BioCardia pay dividends?
BioCardia pays a quarterly dividend. This is distributed in the months of .
How secure is the dividend of BioCardia?
BioCardia paid dividends every year for the past 0 years.
What is the dividend of BioCardia?
For the upcoming 12 months, dividends amounting to 0 USD are expected. This corresponds to a dividend yield of 0 %.
In which sector is BioCardia located?
BioCardia is assigned to the 'Health' sector.
Wann musste ich die Aktien von BioCardia kaufen, um die vorherige Dividende zu erhalten?
To receive the latest dividend of BioCardia from 5/4/2024 amounting to 0 USD, you needed to have the stock in your portfolio before the ex-date on 5/4/2024.
When did BioCardia pay the last dividend?
The last dividend was paid out on 5/4/2024.
What was the dividend of BioCardia in the year 2023?
In the year 2023, BioCardia distributed 0 USD as dividends.
In which currency does BioCardia pay out the dividend?
The dividends of BioCardia are distributed in USD.
Stock savings plans offer an attractive way for investors to build wealth over the long term. One of the main advantages is the so-called cost-average effect: by regularly investing a fixed amount in stocks or stock funds, you automatically buy more shares when prices are low, and fewer when they are high. This can lead to a more favorable average price per share over time. In addition, stock savings plans allow small investors access to expensive stocks, as they can participate with small amounts. Regular investment also promotes a disciplined investment strategy and helps to avoid emotional decisions, such as impulsive buying or selling. Furthermore, investors benefit from the potential appreciation of the stocks as well as from dividend distributions, which can be reinvested, enhancing the compounding effect and thus the growth of the invested capital.
Andere Kennzahlen von BioCardia
Our stock analysis for BioCardia Revenue stock includes important financial indicators such as revenue, profit, P/E ratio, P/S ratio, EBIT, as well as information on dividends. We also assess aspects such as stocks, market capitalization, debt, equity, and liabilities of BioCardia Revenue. If you are looking for more detailed information on these topics, we offer comprehensive analyses on our subpages.
